- About Us
- My Account
The views expressed are those of the author at the time of writing. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional, institutional, or accredited investors only.
Asset managers can help drive progress by conducting deep research to support the projects with the best prospects of fueling impactful results.
The world faces a host of daunting challenges, from the lingering pandemic to the effects of climate change. And yet, I can’t help but remain optimistic about the potential for science and innovation to solve some of our most pressing issues. After all, over three decades of investing in health care, I’ve seen firsthand the power that new ideas, backed by research and capital, have to cure diseases, produce lifesaving vaccines, and improve patient outcomes.
The same spirit of progress is solving problems on a global scale. In my view, we are in the early days of an age of innovation driving real-world solutions, tangible progress, and long-term growth.
Let’s start with the industry I know best. My colleagues and I are as excited as ever about the countless disruptive technologies poised to reshape health care. Today, scientists are tackling disease-causing biology at unprecedented rates and with novel modalities. Decades of research have led us to what I believe is one of the most promising moments in the history of health care, where ideas that once seemed like science fiction are quickly becoming a reality.
In cancer, antibody drug conjugates now allow oncologists to attach a chemotherapy to an antibody and deliver treatment in a more targeted, efficacious, and tolerable way. Likewise, targeted protein degradation can hijack the body’s “garbage disposals” to eliminate proteins that cause specific diseases. This enables treatments that go after targets that were not previously addressable by traditional means.
In my view, as we approach this new frontier in health care, it is easy to be hopeful. The near future will see the potential for technologies like RNA interference and gene therapy to cure numerous rare and serious diseases. In the wake of the pandemic, mRNA vaccines and related technology could combat viruses far beyond COVID, such as RSV and the flu. Finally, artificial intelligence and machine learning are poised to help researchers rapidly identify new treatment targets and drugs at a speed that outpaces traditional drug discovery methods.
At the same time, I believe one of the world’s biggest challenges — climate change — will increasingly be tackled by innovative technological solutions. At Wellington Management, climate risk is an integral part of our research. Through our partnerships with the Woodwell Climate Research Center and MIT, we are constantly integrating physical and transition risks into our analysis. Combining the scientific insights of these organizations with our in-depth industry research, we’re putting capital behind climate technology innovations that could help the world mitigate and adapt to the problems posed by a changing climate.
The next generation of community solar and integrated circuit panels offers new hardware solutions to the energy crisis. Groundbreaking alternative meat substitutes will make the food we eat more sustainable while AI-powered recycling will help to limit waste around the globe. These are just a few of the technological developments that will be brought to bear in the battle against climate change and the pursuit of a more sustainable future.
Health care and climate change are just two of innumerable areas where the private sector is powering much-needed progress. I believe asset managers and asset owners have a key role to play in this progress by providing capital to disruptive companies across public and private markets.
There are countless innovators attempting to solve the world’s problems and limited capital to fund these projects. Asset managers can positively influence these efforts by conducting deep research to support the projects with the best prospects of fueling impactful results.
It is crucial to confront the world’s greatest challenges with a realistic understanding of the tasks in front of us. But I also believe we must remain optimistic about the potential for big ideas to tackle these issues head on. Though the problems we face are understandably top of mind, it’s important to remember the innovative thinkers working tirelessly in the background. In my view, as we enter the age of innovation, human ingenuity is more than capable of overcoming the challenges ahead.
Featured Unique Perspectives
Driving positive outcomes: Our 2022 ESG research agenda
Director of ESG Research Carolina San Martin highlights key areas of focus for 2022, including talent management, supply chain accountability, and climate action — particularly with respect to biodiversity.
China internet: Identifying opportunities amid economic reopening
China’s re-opening and economic recovery from its zero-COVID policy has bolstered our optimism in Chinese internet companies.
Thematic investing focus: The future of food
The global food system has reached a tipping point and change is coming, creating investment opportunities aided by demographic, policy, and innovation tailwinds.
Navigating the new global economy in 2023
This executive summary distills the points of view of several of our 2023 Outlook authors. Discover the risks and opportunities they see as we enter a new economic and market regime.
Health care outlook for 2023
Looking ahead to 2023, members of our health care team see meaningful innovation, supportive valuations, and a benign political and regulatory backdrop across biopharma, medical tech, and health care services sectors.
The fintech revolution is just beginning. Explore the full potential of fintech innovation across public and private markets.
Fintech opportunities after the recent pullback
In four short videos, our fintech investors explore the sector's outlook amid today’s dispersion and highlight the long-term growth potential in payments, fintech incumbents, and crypto innovation.
Thematic investing focus: The transportation revolution has arrived
New technology and environmental concerns are creating a disruptive force in the transportation sector, leading to supply-chain investments and a host of new addressable markets.
Have we reached the end of a tech era?
Thematic Strategist Trevor Noren explores how active management and a global lens could provide tech investors with essential edges moving forward.
Pivot points: Five portfolio positioning ideas for the new market regime
Multi-Asset Strategist Adam Berger looks at five ways in which the world may be very different in the coming decade and how they could influence the next wave of investment winners.
Fintech market overview: The intersection of disruption and dispersion
In the latest episode of WellSaid, Portfolio Manager Matt Lipton and Global Industry Analyst Matt Ross join host Thomas Mucha to discuss their outlook for fintech in today's environment, exploring the recent pullback in the sector, disruptive fintech innovations, potential regulation, and much more.
The allocator’s landscape: Three areas of attention for 2023
Natasha Brook-Walters, Co-Head of Investment Strategy, discusses downside mitigation given the shifting equity/bond correlation, the impact of cyclical and macro volatility, and opportunities to position for long-term change.